These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2182032)

  • 1. Effect of different insulin regimens on plasma lipoprotein and apolipoprotein concentrations in patients with non-insulin-dependent diabetes mellitus.
    Lindström T; Arnqvist HJ; Olsson AG
    Atherosclerosis; 1990 Mar; 81(2):137-44. PubMed ID: 2182032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein subfraction composition in non-insulin-dependent diabetes treated by diet, sulphonylurea, and insulin.
    Billingham MS; Milles JJ; Bailey CJ; Hall RA
    Metabolism; 1989 Sep; 38(9):850-7. PubMed ID: 2671598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy.
    Bagdade JD; Buchanan WE; Kuusi T; Taskinen MR
    Arteriosclerosis; 1990; 10(2):232-9. PubMed ID: 2180397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
    Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
    Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Brunner D
    Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.
    Taskinen MR; Packard CJ; Shepherd J
    Diabetes; 1990 Sep; 39(9):1017-27. PubMed ID: 2200727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein subfraction composition in non-obese newly diagnosed non-insulin dependent diabetes after treatment with diet and glibenclamide.
    Billingham MS; Milles JJ; Bailey CJ; Hall RA
    Diabetes Res; 1989 May; 11(1):13-20. PubMed ID: 2515931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.
    Ruotolo G; Parlavecchia M; Taskinen MR; Galimberti G; Zoppo A; Le NA; Ragogna F; Micossi P; Pozza G
    Diabetes Care; 1994 Jan; 17(1):6-12. PubMed ID: 8112191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial aggregation of non-insulin dependent diabetes and coronary heart disease are accompanied by different effects on serum lipids, lipoproteins and apolipoproteins.
    Sarlund H; Laakso M; Voutilainen E; Penttilä I; Pyörälä K
    Atherosclerosis; 1991 Jan; 86(1):17-29. PubMed ID: 2064632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein composition and HDL particle size distribution in women with non-insulin-dependent diabetes mellitus and the effects of probucol treatment.
    Lane JT; Subbaiah PV; Otto ME; Bagdade JD
    J Lab Clin Med; 1991 Aug; 118(2):120-8. PubMed ID: 1856575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men.
    Bagdade JD; Subbaiah PV
    Diabetes; 1989 Oct; 38(10):1226-30. PubMed ID: 2507376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.
    Prager R; Schernthaner G; Kostner GM; Mühlhauser I; Zechner R; Dorda W
    Atherosclerosis; 1982 Jun; 43(2-3):321-7. PubMed ID: 6810904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of a biphasic oral contraceptive preparation containing ethinyloestradiol and desogestrel on serum lipoproteins and apolipoproteins.
    Voorhoof L; Rosseneu M; Caster H; De Keersgieter W
    J Endocrinol; 1986 Oct; 111(1):191-6. PubMed ID: 2946795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
    Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
    Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
    Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein composition in the insulin-deficient non-acidotic phase of type I diabetic patients and early evolution after the start of insulin therapy.
    Reverter JL; Sentí M; Rubiés-Prat J; Lucas A; Salinas I; Pizarro E; Pedro-Botet J; Sanmartí A
    Clin Chim Acta; 1993 Dec; 223(1-2):113-20. PubMed ID: 8143357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
    Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipoprotein profile differs during insulin treatment alone and combination therapy with insulin and sulphonylureas in patients with Type 2 diabetes mellitus.
    Lindström T; Nyström FH; Olsson AG; Ottosson AM; Arnqvist HJ
    Diabet Med; 1999 Oct; 16(10):820-6. PubMed ID: 10547208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E.
    Knopp RH; Walden CE; Warnick GR; Albers JJ; Ginsberg J; McGinnis BM
    Am J Med; 1987 Nov; 83(5B):75-84. PubMed ID: 3120587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM.
    Abate N; Vega GL; Garg A; Grundy SM
    Atherosclerosis; 1995 Nov; 118(1):111-22. PubMed ID: 8579621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.